KWON, Taek Kwan,LEE, Kwang Young,IM, Ho Taek,KIM, Yong Il,PARK, Jae Hyun,WOO, Jong Soo
申请号：
PH12019500154
公开号：
PH12019500154A1
申请日:
2019.01.21
申请国别(地区):
PH
年份:
2019
代理人:
摘要：
The present invention relates to a pharmaceutical formulation containing esomeprazole or a pharmaceutically acceptable salt thereof. The pharmaceutical formulation according to the present invention has remarkably improved pH-dependent drug-release characteristics of esomeprazole or the pharmaceutically acceptable salt thereof, and thus the release of esomeprazole or the pharmaceutically acceptable salt thereof can be started from a predetermined point in time after a desired lapse of time after the oral administration of the same, the release occurs for the desired period of time, and the release can also be completed after a predetermined lapse of time, such that, compared to those of other conventional formulations, excellent convenience and therapeutic effects for the patient can be expected.
